UPLOAD Filing
Cocrystal Pharma, Inc.
Date: Aug. 28, 2025 · CIK: 0001412486 · Accession: 0000000000-25-009282
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-38418
Letter
Re: Cocrystal Pharma, Inc. Form 10-K for the fiscal year ended December 31, 2024 Filed March 31, 2025 File No. 001-38418 Dear James Martin:
August 28, 2025
James Martin Co-Chief Executive Officer and CFO Cocrystal Pharma, Inc. 19805 North Creek Parkway Bothell, WA 98011
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> August 28, 2025 James Martin Co-Chief Executive Officer and CFO Cocrystal Pharma, Inc. 19805 North Creek Parkway Bothell, WA 98011 Re: Cocrystal Pharma, Inc. Form 10-K for the fiscal year ended December 31, 2024 Filed March 31, 2025 File No. 001-38418 Dear James Martin: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences </TEXT> </DOCUMENT>